Intentionally Infecting Humans: Is it Ethical?
Autor Seema K. Shahen Limba Engleză Hardback – 4 iun 2026
Preț: 218.15 lei
Preț vechi: 309.58 lei
-30% Nou
Puncte Express: 327
Carte disponibilă
Livrare economică 04-09 septembrie
Livrare express 21-27 august pentru 104.16 lei
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit de la 400.00 lei Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780197667897
ISBN-10: 0197667899
Pagini: 288
Dimensiuni: 151 x 212 x 29 mm
Greutate: 0.42 kg
Editura: Oxford University Press
Colecția OUP USA
Locul publicării:New York, United States
ISBN-10: 0197667899
Pagini: 288
Dimensiuni: 151 x 212 x 29 mm
Greutate: 0.42 kg
Editura: Oxford University Press
Colecția OUP USA
Locul publicării:New York, United States
Recenzii
This book is a tour de force! Shah weaves history and ethical analysis to deliver an insightful, nuanced, and forward-thinking study of controlled human infection research. Taking readers beyond dichotomies, Shah makes a compelling case that controlled human infection research sometimes is more - and sometimes less - ethically complex than we might think.
Can you intentionally infect a person with a deadly bacteria or virus? In a lucid and tremendously insightful book, Seema Shah explores the history and controversies surrounding this question, concluding that such infections can be ethical. But she also cautions against deeming them "quick fixes" for emergencies like COVID. Medical research, global health, and bioethics will be the better for following Shah's excellent guidance on this thorniest of research ethics questions.
Intentionally Infecting Humans is the most thorough treatment to date of the thorny ethical issues that are part of controlled human infection (CHI) research. Shah situates her analysis in the history of CHI studies to navigate a path to future, ethically sound uses of this controversial research approach.
Seema Shah's rigorous and timely analysis brings that tension into sharp focus. Shah's treatment of public trust-not as a background condition but as an active, fragile resource that policymakers must steward-resonates deeply with the realities we navigate daily, particularly in the developing world, which houses both the bulk of the infectious disease burden and a skepticism about clinical research built on sometimes exploitative practices. She argues rightly that looser risk thresholds cannot be justified in emergencies. Equally important is her call to elevate the status of research participants, whose contributions to science are too rarely recognized and too easily exploited. This book deserves a central place in policy conversations about where research is done, how it is governed, and whose interests it ultimately serves.
an insightful and engaging book... [Shah] provides a comprehensive review of the chequered ethical history of these studies... She draws an important distinction between more established challenge models... and models using novel agents, such as was the case with SARS-CoV-2 and Zika, when special ethical review may be beneficial. The book will be of special interest to those contemplating conducting challenge studies and to those who might envisage volunteering to participate, as well as to funders and sponsors of these studies. It is written in a style that will both engage a general audience and encourage debate...
Can you intentionally infect a person with a deadly bacteria or virus? In a lucid and tremendously insightful book, Seema Shah explores the history and controversies surrounding this question, concluding that such infections can be ethical. But she also cautions against deeming them "quick fixes" for emergencies like COVID. Medical research, global health, and bioethics will be the better for following Shah's excellent guidance on this thorniest of research ethics questions.
Intentionally Infecting Humans is the most thorough treatment to date of the thorny ethical issues that are part of controlled human infection (CHI) research. Shah situates her analysis in the history of CHI studies to navigate a path to future, ethically sound uses of this controversial research approach.
Seema Shah's rigorous and timely analysis brings that tension into sharp focus. Shah's treatment of public trust-not as a background condition but as an active, fragile resource that policymakers must steward-resonates deeply with the realities we navigate daily, particularly in the developing world, which houses both the bulk of the infectious disease burden and a skepticism about clinical research built on sometimes exploitative practices. She argues rightly that looser risk thresholds cannot be justified in emergencies. Equally important is her call to elevate the status of research participants, whose contributions to science are too rarely recognized and too easily exploited. This book deserves a central place in policy conversations about where research is done, how it is governed, and whose interests it ultimately serves.
an insightful and engaging book... [Shah] provides a comprehensive review of the chequered ethical history of these studies... She draws an important distinction between more established challenge models... and models using novel agents, such as was the case with SARS-CoV-2 and Zika, when special ethical review may be beneficial. The book will be of special interest to those contemplating conducting challenge studies and to those who might envisage volunteering to participate, as well as to funders and sponsors of these studies. It is written in a style that will both engage a general audience and encourage debate...
Notă biografică
Seema K. Shah, JD, is Founder's Board Professor of Medical Ethics at Lurie Children's Hospital, Northwestern's Feinberg School of Medicine, and Pritzker School of Law (by courtesy). Shah's research focuses on pediatric and global health research ethics,particularly related to controlled human infection (CHI). Shah received a law degree from Stanford Law School and completed a bioethics fellowship at the National Institutes of Health (NIH). She was elected as a Hastings Center Fellow, chaired a panel on the ethics of Zika virus CHI research for NIH, and serves as an expert advisor to the World Health Organization on CHI research.